224168-68-7

Usage

Uses

Used in Pharmaceutical and Medicinal Chemistry Research:
3(S)-Iodomethyl-pyrrolidine-1-carboxylic acid tert-butyl ester is used as a key intermediate in the synthesis of various pharmaceutical compounds. Its unique structure allows for the creation of new drugs and biologically active molecules with potential therapeutic applications.
Used in Organic Synthesis:
In the field of organic synthesis, 3(S)-iodomethyl-pyrrolidine-1-carboxylic acid tert-butyl ester is used as a building block for constructing complex organic molecules. The tert-butyl ester group provides a handle for further functionalization, while the iodomethyl group offers opportunities for cross-coupling reactions, leading to the formation of a wide range of organic compounds.
Used in Drug Development:
3(S)-Iodomethyl-pyrrolidine-1-carboxylic acid tert-butyl ester is employed as a crucial component in the development of new drugs. Its versatility in organic synthesis and ability to be incorporated into target molecules make it an indispensable tool in the design and synthesis of novel therapeutic agents.
Used in Chemical Research:
In the realm of chemical research, 3(S)-iodomethyl-pyrrolidine-1-carboxylic acid tert-butyl ester is utilized as a model compound to study various chemical reactions and mechanisms. Its unique properties and reactivity provide valuable insights into the behavior of similar compounds and contribute to the advancement of chemical knowledge.

Upstream product

• 140148-70-5 (S)-1-N-boc-β-proline 
• 199174-24-8 tert-butyl (3S)-3-(hydroxymethyl)pyrrolidine-1-carboxylate 

Relevant academic research and scientific papers

NOVEL PHENYLACETAMIDE COMPOUND AND PHARMACEUTICAL CONTAINING SAME

The present invention is to create a compound that selectively activates glucokinase in the liver, and in particular, to provide an agent for treating and preventing diabetes and impaired glucose tolerance, wherein the agent has a low hypoglycemia risk. A

TRICYCLIC COMPOUNDS FOR USE IN THE TREATMENT AND/OR CONTROL OF OBESITY

The invention provides tricyclic compounds and their use in treating medical disorders, such as obesity. Pharmaceutical compositions and methods of making various tricyclic compounds are provided. The compounds are contemplated to have activity against me

METHODS OF TREATING LIVER DISEASES

The invention provides tricyclic compounds and their use in treating liver disorders, such as non-alcoholic steatohepatitis and related disorders (e.g., fibrosis). The compounds are contemplated to have activity against methionyl aminopeptidase 2.

INDAZOLE- AND PYRROLOPYRIDINE-DERIVATIVE AND PHARMACEUTICAL USE THEREOF

The present invention relates to a novel indazole- or pyrrolopyridine-derivative, represented by the formula (1) below, that has an agonistic action or a partial agonistic action against serotonin-4 receptor, and a pharmaceutical composition comprising the same. Formula (1) [wherein each substituent is as defined in claim 1]

PARTIALLY SATURATED TRICYCLIC COMPOUNDS AND METHODS OF MAKING AND USING SAME

The invention provides tricyclic compounds and their use in treating medical disorders, such as obesity. Pharmaceutical compositions and methods of making various tricyclic compounds are provided. The compounds are contemplated to have activity against methionyl aminopeptidase 2.